One of the highlights of Oracle Health Sciences Connect is the chance to hear from some of our customers about their experience in adopting and implementing Clinical One. It helps us better understand how we can make their difficult jobs easier, and helps other customers better understand some of the advantages offered by a unified platform.

At this year's North America event, one of our customer panels revealed a few significant areas that were positively impacted by the move Clinical One. The positive impacts experienced included streamlined study design and study changes, flexible enhancement adoption, and interactive training and opportunity to share product feedback during implementation.

At Sunovion, Randomization and Trial Supply Management (RTSM) is an important component of a number of key clinical trials, noted April Mascia, Director of Clinical Trials Material Management. One of the major challenges in such trials, particularly in Phase III, is the need to make significant revisions as the company reviews initial data. Clinical One's approach to RTSM, she said, has streamlined that key process.

"We were looking for a way to more quickly make changes," she said, such as adding cohorts or altering the treatment or dosing schedule mid-trial. "Now that we've implemented Clinical One, we have that flexibility...without much impact to budget or timeline."